Status:
COMPLETED
ORiginal meThodology for Assessing the Impact of the Coronavirus Health Crisis on Psychotropic Drug Use
Lead Sponsor:
Nantes University Hospital
Conditions:
Psychotropic Drugs
Eligibility:
All Genders
16+ years
Brief Summary
The health crisis linked to the coronavirus has had a significant impact on the mental health. The question of the repercussion of this crisis on the consumption of psychotropic drugs is crucial. It i...
Detailed Description
The project will allow studying the evolution of the use of psychotropics since the coronavirus-related health crisis according to the temporality of consumption (succession and/or concomitance of con...
Eligibility Criteria
Inclusion
- Subjects identified in the French National Healthcare Data System (SNDS) in 2018, 2019, 2020 and 2021 at national level, alive on 01/01/2018, age ≥ 16 years on 01/01/2020.
Exclusion
- Institutionalization at least one day in a residential facility for dependent elderly people with an internal pharmacy in 2018, 2019, 2020 or 2021.
Key Trial Info
Start Date :
January 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 12 2024
Estimated Enrollment :
2772093 Patients enrolled
Trial Details
Trial ID
NCT05395897
Start Date
January 1 2023
End Date
December 12 2024
Last Update
May 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nantes university hospital
Nantes, Loire-atlantique, France, 44093